Skip to content

The effect of Stopcivir syrup in patients with COVID-19

Evaluating efficacy and safety of Stopcivir (Zataria multiflora Boiss+ Alium Sativum+ Heracleum persicum+ Satureja hortensis+ Dianthus+ Foeniculum vulgare+ opium) syrup on length of hospitalization in patients with COVID-19

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200411047016N1
Enrollment
150
Registered
2020-05-31
Start date
2020-04-05
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID- 19. Coronavirus infection, unspecified

Interventions

Intervention 1: Intervention group: In this study, the content of specific ratios of garlic, Lamiaceae, Heracleum persicum, Dianthus, Satureja hortensis plus a little opium in an alcohol-based solven

Sponsors

Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: The definitive case of covid 19 based on laboratory confirmation Diagnosis of covid 19 based on CT or chest radiography Patients between 18-75 years

Exclusion criteria

Exclusion criteria: The presence of comorbidities (sever renal failure, sever liver failure, CHF, major cerebrovascular and cardiovascular disease, chronic lung disease, malignancy, immune system diseases including AIDS, encephalopathy) Pregnancy and lactation History of allergies to herbal drugs Crisis and severe cases

Design outcomes

Primary

MeasureTime frame
Length of hospitalization. Timepoint: Hospitalization time and Hospital discharge time. Method of measurement: Check List.;Shortness of breath. Timepoint: Variable will be completed in the form of a checklist at the beginning of the Hospitalization and daily until the end of hospitalization. Method of measurement: Check list.;Oxygen saturation. Timepoint: Variable will be completed in the form of a checklist at the beginning of the Hospitalization and daily until the end of hospitalization. Method of measurement: Check list.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyedeh Sedigheh Yousefi

Mazandaran University of Medical Sciences

s.yousefi@mazums.ac.ir+98 11 3324 4893

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026